Ion Agirrezabal

9PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 08, 2025
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.

Manuel De la Torre-Aláez, Ana Matilla, María Varela

|Oct 16, 2024
Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma.

Ion Agirrezabal, Richard F Pollock, Phuong Lien Carion

|Feb 26, 2024
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis.

André L F Azeredo-da-Silva, Victor Hugo F de Jesus, Ion Agirrezabal

|May 04, 2023
Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil.

Ion Agirrezabal, Luiz Sérgio Pereira Grillo Junior, Felipe Nasser

|Nov 01, 2022
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England.

Richard F Pollock, Suki Shergill, Phuong Lien Carion

|Mar 13, 2022
Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.

Ion Agirrezabal, Victoria K Brennan, Fabien Colaone

Pageof 2

Frequent Collaborators

6 joint publications

Victoria K Brennan

6 joint publications

Suki Shergill

4 joint publications

Richard F Pollock

3 joint publications

Fabien Colaone